相关实验视频

Updated: Jul 1, 2025

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

腺氨酸A_2B受体激动剂改善表皮屏障完整性表皮增生症的小鼠模型

Asunción Marín-Castejón¹, Miguel Marco-Bonilla², M Carmen Terencio¹

¹Department of Pharmacology, Faculty of Pharmacy and Food Sciences, University of Valencia, Av. Vicent Andrés Estellés s/n, Burjassot 46100, Valencia, Spain; Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM), University of Valencia, Polytechnic University of Valencia, Av. Vicent A. Estellés s/n, Burjassot 46100, Valencia, Spain.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|March 9, 2024

概括

在A2B腺受体 (A2BAR) 激动剂BAY60-6583减少皮肤炎症和增殖. A_2BAR激活也保留了皮肤屏障,这表明它是炎症性皮肤疾病的治疗点.

科学领域:

皮肤病学皮肤病学
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

氨酸受体,特别是A_2BAR,是生理过程的关键调节者.
A_2BAR在表皮中高度表达,并影响质细胞的行为.
之前的研究表明,A_2BAR激动剂BAY60-6583在人类角质细胞中具有抗增殖和抗炎作用.

研究的目的:

为了研究局部A_2BAR激动剂BAY60-6583在表皮增生的小鼠模型中的治疗潜力.
评估A_2BAR激活对炎症性皮肤疾病和表皮屏障功能的影响.

主要方法:

在TPA诱导的小鼠皮肤炎症模型中,局部应用BAY60-6583 (BAY) 或选择性A_2BAR抗剂PSB-1115 (PSB).
评估炎症反应,表皮超增殖,阿坎索斯,以及增殖性角质细胞标记物的表达.
评估表皮屏障蛋白的表达和完整性.

主要成果:

局部BAY应用显著降低了TPA诱导的炎症,皮肤病变,过度增殖和.
用PSB-1115进行预治疗逆转了BAY的保护作用,而单独使用PSB会加剧皮肤损伤.
BAY治疗使表皮屏障蛋白表达正常化,而PSB治疗使屏障完整性恶化.

结论:

A_2BAR激活在表皮表现出显著的抗炎和抗增殖作用.
A_2BAR在维持表皮屏障完整性方面发挥着至关重要的作用.
准A_2BAR代表了对像牛皮这样的炎症性皮肤疾病的有前途的治疗策略.

关键词:

腺氨酸A2B受体的受体卡斯帕-14,一个可靠的酶.皮表膜屏障是一种屏障.菲拉格林 (Filaggrin) 是一个笑话.这里涉及到rin.牛皮是一种病.

更多相关视频

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

Published on: March 17, 2018

Isolation and Culture of Primary Mouse Keratinocytes from Neonatal and Adult Mouse Skin

Isolation and Culture of Primary Mouse Keratinocytes from Neonatal and Adult Mouse Skin

Published on: July 14, 2017

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

Renewal of Skin Epidermal Stem Cells

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...

Adrenergic Receptors: ɑ Subtype

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...